Skip to content

Efficacy of Rasanadarvyadi kashay and Lodhrabilwadi kashay in the management of Udavartini Yonivyapad (Primary Dysmenorrhea).

Randomized Controlled Clinical Study to Evaluate the Efficacy Of Rasanadarvyadi kashay in the management of Udavartini Yonivyapad (Primary Dysmenorrhea). - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075041
Enrollment
100
Registered
2024-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Dr Bhagyashri Shivcharan Madghe
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female patient age group from 12 years to 30 years unmarried patient. 2.Patient with lower abdominal pain, lumbar pain, nausea,vomiting during menstrual cycle.

Exclusion criteria

Exclusion criteria: 1.Patients of pelvic pathology i.e PID,PCOD,Cervical stenosis,Fibroid, Endometriosis,DUB,Adenomyosis,Endometrial polyp. 2.Patient taking anyn hormonal therapy. 3.Patient with Congenital Anomalies of reproductive system.

Design outcomes

Primary

MeasureTime frame
To study the effect of Rasanadarvyadi kashay in the management of Udavartini yonivyapadTimepoint: Baseline- 30th,60th,90th day

Secondary

MeasureTime frame
1.To study Udavartini yonivyapad according to Ayurveda. 2.To study Primary Dysmenorrhea according to Modern. 3.To compare the effect of Rasanadarvyadi kashay and Lodhrabilvadi kashay in the management of Udavartini Yonivyapad.Timepoint: Baseline- 30th,60th,90th day

Countries

India

Contacts

Public ContactDr. Bhagyashri Shivcharan Madghe

CSMSS Ayurved Mahavidyalaya and Rugnalaya, Kanchanwadi, Paithan road,Aurangabad, 431011,Maharashtra.

dryennawar11@gmail.com9850562526

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026